SCHEDULE 13G/A: AWM Investment Company Discloses 6.0% Stake in SANUWAVE Health, Inc.

AWM Investment Company, Inc. has filed an amended Schedule 13G, reporting a 6.0% beneficial ownership stake in SANUWAVE Health, Inc. as of May 9, 2025.

Summary

• AWM Investment Company, Inc. (AWM), a Delaware corporation, filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in SANUWAVE Health, Inc.
• AWM serves as the investment adviser to four funds: Special Situations Cayman Fund, L.P. (CAYMAN), Special Situations Fund III QP, L.P. (SSFQP), Special Situations Private Equity Fund, L.P. (SSPE), and Special Situations Life Sciences Fund, L.P. (SSLS).
• AWM beneficially owns an aggregate of 513,230 shares of SANUWAVE Health, Inc. Common Stock.
• This ownership represents 6.0% of the total class of securities.
• AWM holds sole voting power and sole dispositive power over all 513,230 shares.
• The shares are distributed among the funds as follows: CAYMAN holds 78,748 shares, SSFQP holds 283,444 shares, SSPE holds 79,807 shares, and SSLS holds 71,231 shares.
• David M. Greenhouse and Adam C. Stettner are identified as controlling principals of AWM and members of the general partners of the respective funds.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: The filing indicates a significant institutional investment, which is generally a positive signal of confidence in the company, even though it's a passive stake. No negative information is present.

Positives

• AWM Investment Company, a professional investment adviser, holds a significant 6.0% stake, indicating institutional interest in SANUWAVE Health, Inc.
• The filing confirms the shares are held in the ordinary course of business, suggesting a passive, long-term investment perspective rather than an activist intent to change control.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding SANUWAVE Health, Inc.'s future performance or strategic direction, as it is solely a beneficial ownership report.

Industry Context

This Schedule 13G filing indicates that AWM Investment Company, Inc., an investment adviser specializing in various funds, has taken a significant passive stake in SANUWAVE Health, Inc. This reflects a typical institutional investment activity where a fund manager acquires shares for its clients, aligning with broader trends of professional money managers building positions in publicly traded companies.

Related Party Transactions

• AWM Investment Company, Inc. acts as the investment adviser to Special Situations Cayman Fund, L.P., Special Situations Fund III QP, L.P., Special Situations Private Equity Fund, L.P., and Special Situations Life Sciences Fund, L.P., which collectively hold the reported shares. David M. Greenhouse and Adam C. Stettner are controlling principals of AWM and members of the general partners of these funds.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake by AWM Investment Company, Inc. may be viewed positively by existing and potential shareholders, signaling confidence from a professional investment firm.

Key Dates

Keywords

SANUWAVE Health Inc., AWM Investment Company Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Investment Adviser, SEC Filing, Shareholder Stake